Whole body hyperthermia: A potent radioprotector in vivo

Rong Nian Shen, Ned B. Hornback, Homayoon Shidnia, Bo Wu, Li Lu, Hal Broxmeyer

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Interleukin-1 has been reported to be an effective radioprotective agent in mice subjected to lethal doses of irradiation. Production of Interleukin-1 can be increased by whole body hyperthermia. Therefore, whole body hyperthermia was assessed for its efficacy in protecting the lethal effects of ionizing radiation in DBA/2 mice. One hour of 40°C ± 0.2 whole body hyperthermia given 20 hr before 900 cGy total body irradiation protected 100% of DBA/2 mice from an LD 100/16 radiation dose (dose of irradiation that killed 100% of the mice in 16 days). Lethal doses of total body irradiation produced profound monocytopenia, decreased cellularity of thymus, spleen, and bone marrow, and suppressed Interleukin-1 production. Interleukin-1 production was determined using the thymocyte proliferation assay. Whole body hyperthermia accelerated recovery of blood leukocytes by up to 5 days post-total body irradiation in DBA/2 mice. Thymocytes, spleen, and bone marrow cells were activated by whole body hyperthermia, as assessed by the cell's response to Concanavalin A. This was accompanied by accelerated Interleukin-1 generation. Our results provide the first evidence that whole body hyperthermia acts as a potent radioprotector in vivo, effects that may be mediated by Interleukin-1.

Original languageEnglish
Pages (from-to)525-530
Number of pages6
JournalInternational Journal of Radiation Oncology Biology Physics
Volume20
Issue number3
DOIs
StatePublished - 1991

Fingerprint

hyperthermia
Interleukin-1
interleukins
Fever
Inbred DBA Mouse
Whole-Body Irradiation
mice
Thymocytes
irradiation
dosage
spleen
Spleen
bone marrow
Radiation-Protective Agents
antiradiation drugs
Concanavalin A
Ionizing Radiation
Bone Marrow Cells
Thymus Gland
leukocytes

Keywords

  • Interleukin-1
  • Radioprotector
  • Total body irradiation
  • Whole body hyperthermia

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiation

Cite this

Whole body hyperthermia : A potent radioprotector in vivo. / Shen, Rong Nian; Hornback, Ned B.; Shidnia, Homayoon; Wu, Bo; Lu, Li; Broxmeyer, Hal.

In: International Journal of Radiation Oncology Biology Physics, Vol. 20, No. 3, 1991, p. 525-530.

Research output: Contribution to journalArticle

Shen, Rong Nian ; Hornback, Ned B. ; Shidnia, Homayoon ; Wu, Bo ; Lu, Li ; Broxmeyer, Hal. / Whole body hyperthermia : A potent radioprotector in vivo. In: International Journal of Radiation Oncology Biology Physics. 1991 ; Vol. 20, No. 3. pp. 525-530.
@article{f421ca3af3d04711aa340e2d0c0429b1,
title = "Whole body hyperthermia: A potent radioprotector in vivo",
abstract = "Interleukin-1 has been reported to be an effective radioprotective agent in mice subjected to lethal doses of irradiation. Production of Interleukin-1 can be increased by whole body hyperthermia. Therefore, whole body hyperthermia was assessed for its efficacy in protecting the lethal effects of ionizing radiation in DBA/2 mice. One hour of 40°C ± 0.2 whole body hyperthermia given 20 hr before 900 cGy total body irradiation protected 100{\%} of DBA/2 mice from an LD 100/16 radiation dose (dose of irradiation that killed 100{\%} of the mice in 16 days). Lethal doses of total body irradiation produced profound monocytopenia, decreased cellularity of thymus, spleen, and bone marrow, and suppressed Interleukin-1 production. Interleukin-1 production was determined using the thymocyte proliferation assay. Whole body hyperthermia accelerated recovery of blood leukocytes by up to 5 days post-total body irradiation in DBA/2 mice. Thymocytes, spleen, and bone marrow cells were activated by whole body hyperthermia, as assessed by the cell's response to Concanavalin A. This was accompanied by accelerated Interleukin-1 generation. Our results provide the first evidence that whole body hyperthermia acts as a potent radioprotector in vivo, effects that may be mediated by Interleukin-1.",
keywords = "Interleukin-1, Radioprotector, Total body irradiation, Whole body hyperthermia",
author = "Shen, {Rong Nian} and Hornback, {Ned B.} and Homayoon Shidnia and Bo Wu and Li Lu and Hal Broxmeyer",
year = "1991",
doi = "10.1016/0360-3016(91)90065-C",
language = "English",
volume = "20",
pages = "525--530",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Whole body hyperthermia

T2 - A potent radioprotector in vivo

AU - Shen, Rong Nian

AU - Hornback, Ned B.

AU - Shidnia, Homayoon

AU - Wu, Bo

AU - Lu, Li

AU - Broxmeyer, Hal

PY - 1991

Y1 - 1991

N2 - Interleukin-1 has been reported to be an effective radioprotective agent in mice subjected to lethal doses of irradiation. Production of Interleukin-1 can be increased by whole body hyperthermia. Therefore, whole body hyperthermia was assessed for its efficacy in protecting the lethal effects of ionizing radiation in DBA/2 mice. One hour of 40°C ± 0.2 whole body hyperthermia given 20 hr before 900 cGy total body irradiation protected 100% of DBA/2 mice from an LD 100/16 radiation dose (dose of irradiation that killed 100% of the mice in 16 days). Lethal doses of total body irradiation produced profound monocytopenia, decreased cellularity of thymus, spleen, and bone marrow, and suppressed Interleukin-1 production. Interleukin-1 production was determined using the thymocyte proliferation assay. Whole body hyperthermia accelerated recovery of blood leukocytes by up to 5 days post-total body irradiation in DBA/2 mice. Thymocytes, spleen, and bone marrow cells were activated by whole body hyperthermia, as assessed by the cell's response to Concanavalin A. This was accompanied by accelerated Interleukin-1 generation. Our results provide the first evidence that whole body hyperthermia acts as a potent radioprotector in vivo, effects that may be mediated by Interleukin-1.

AB - Interleukin-1 has been reported to be an effective radioprotective agent in mice subjected to lethal doses of irradiation. Production of Interleukin-1 can be increased by whole body hyperthermia. Therefore, whole body hyperthermia was assessed for its efficacy in protecting the lethal effects of ionizing radiation in DBA/2 mice. One hour of 40°C ± 0.2 whole body hyperthermia given 20 hr before 900 cGy total body irradiation protected 100% of DBA/2 mice from an LD 100/16 radiation dose (dose of irradiation that killed 100% of the mice in 16 days). Lethal doses of total body irradiation produced profound monocytopenia, decreased cellularity of thymus, spleen, and bone marrow, and suppressed Interleukin-1 production. Interleukin-1 production was determined using the thymocyte proliferation assay. Whole body hyperthermia accelerated recovery of blood leukocytes by up to 5 days post-total body irradiation in DBA/2 mice. Thymocytes, spleen, and bone marrow cells were activated by whole body hyperthermia, as assessed by the cell's response to Concanavalin A. This was accompanied by accelerated Interleukin-1 generation. Our results provide the first evidence that whole body hyperthermia acts as a potent radioprotector in vivo, effects that may be mediated by Interleukin-1.

KW - Interleukin-1

KW - Radioprotector

KW - Total body irradiation

KW - Whole body hyperthermia

UR - http://www.scopus.com/inward/record.url?scp=0026026398&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026026398&partnerID=8YFLogxK

U2 - 10.1016/0360-3016(91)90065-C

DO - 10.1016/0360-3016(91)90065-C

M3 - Article

C2 - 1995538

AN - SCOPUS:0026026398

VL - 20

SP - 525

EP - 530

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 3

ER -